Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report - PubMed (original) (raw)
Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report
T Konno et al. Eur J Cancer Clin Oncol. 1983 Aug.
Abstract
A clinical evaluation of arterial infusion of high-molecular-weight antitumor agent SMANCS dissolved in lipid lymphographic agent (thiodol) in 44 patients with mostly unresectable hepatoma is described. The treatment regimen demonstrated significant merits both therapeutically and diagnostically. Marked antitumor effects were shown in the decreased serum alpha-fetoprotein levels (86% of cases) and tumor size (95% of cases), and in survival period and histological findings. Furthermore, there was increased diagnostic sensitivity using CT scan, plain X-rays or ultrasound. The procedure of selective arterial administration of 3-4 mg of SMANCS in 3-4 ml of ethiodol per dose was simple to perform and was required only once every 3-4 weeks. Both ethiodol and the drug accumulated more selectively in tumor than in any other tissues and their activity remained for more than 3 weeks. Only minimal side-effects were associated with SMANCS and ethiodol during this study.
Similar articles
- [Intra-arterial injection of an oily antineoplastic agent in hepatic cancer].
Konno T, Tashiro S, Maeda H, Iwai K, Ogata K, Mochinaga M, Uemura K, Ishimaru S, Miyauchi Y, Yokoyama I. Konno T, et al. Gan To Kagaku Ryoho. 1983 Feb;10(2 Pt 2):351-7. Gan To Kagaku Ryoho. 1983. PMID: 6309086 Japanese. - [Arterial administration of high molecular weight antitumor agent, SMANCS dissolved in ethiodol for various malignant solid tumors].
Konno T, Iwai K, Maki S, Uchida M, Ogata K, Tashiro S, Miyauchi Y, Yokoyama I, Maeda H. Konno T, et al. Nihon Gan Chiryo Gakkai Shi. 1983 Oct 20;18(7):1845-51. Nihon Gan Chiryo Gakkai Shi. 1983. PMID: 6323597 Japanese. No abstract available. - [Use of a lipid lymphographic agent, lipiodol, as a carrier of high molecular weight antitumor agent, smancs, for hepatocellular carcinoma].
Konno T, Maeda H, Yokoyama I, Iwai K, Ogata K, Tashiro S, Uemura K, Mochinaga M, Watanabe E, Nakakuma K, Morinaga T, Miyauchi Y. Konno T, et al. Gan To Kagaku Ryoho. 1982 Nov;9(11):2005-15. Gan To Kagaku Ryoho. 1982. PMID: 6307179 Japanese. - [Arterial infusion chemotherapy with SMANCS].
Nekohashi T, Maruno J, Sanjou A, Toda G. Nekohashi T, et al. Nihon Rinsho. 2001 Oct;59 Suppl 6:629-33. Nihon Rinsho. 2001. PMID: 11762025 Review. Japanese. No abstract available.
Cited by
- Biological efficacy of simulated radiolabeled Lipiodol® ultra-fluid and microspheres for various beta emitters: study based on VX2 tumors.
Dieudonné A, Becker S, Soares M, Hollenbeck C, De Goltstein MC, Vera P, Santus R. Dieudonné A, et al. EJNMMI Res. 2023 Nov 23;13(1):101. doi: 10.1186/s13550-023-01051-9. EJNMMI Res. 2023. PMID: 37995042 Free PMC article. - Multidisciplinary Taiwan consensus for the use of conventional TACE in hepatocellular carcinoma treatment.
Chang PY, Lee RC, Liang PC, Liu YS, Chuang VP, Wu DK, Cheng YF, Huang JI, Tseng HS, Hung CF, Wu RH, Chern MC, Cheng HM, Wu CH, Cheng SM, Chiang CL, Liang HL. Chang PY, et al. Front Oncol. 2023 Jun 20;13:1186674. doi: 10.3389/fonc.2023.1186674. eCollection 2023. Front Oncol. 2023. PMID: 37427137 Free PMC article. Review. - Interventional oncology of liver tumors: how it all started and where are we now.
Solbiati LA, Arai Y. Solbiati LA, et al. Br J Radiol. 2022 Sep 1;95(1138):20220434. doi: 10.1259/bjr.20220434. Epub 2022 Jul 12. Br J Radiol. 2022. PMID: 35776630 Free PMC article. Review. - Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma - The Changing Tides.
Khan AR, Wei X, Xu X. Khan AR, et al. J Hepatocell Carcinoma. 2021 Sep 7;8:1089-1115. doi: 10.2147/JHC.S318070. eCollection 2021. J Hepatocell Carcinoma. 2021. PMID: 34522691 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical